<DOC>
	<DOCNO>NCT00139204</DOCNO>
	<brief_summary>The purpose study well understand new type radiology test call positron emission tomography ( PET ) carbon 11 methionine determine patient beneficial effect anti-cancer therapy drug docetaxel .</brief_summary>
	<brief_title>Evaluation Effects Chemotherapy Uptake Retention Carbon 11 Methionine Prostate Cancer Patients</brief_title>
	<detailed_description>In week patient first dose chemotherapy receive C11 methionine PET scan take 90 minute . C11 methionine radioactively label amino acid give patient intravenously . Eighteen twenty day patient first dose docetaxel chemotherapy , another C11 methionine PET scan identical first scan . At end three cycle docetaxel chemotherapy ( 2 1/2 month study ) another C11 methionine PET scan do . The PET scan show well tumor take methionine .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Carbon-11 methionine</mesh_term>
	<criteria>Metastatic hormonerefractory prostate cancer patient plan begin every 3week docetaxel chemotherapy Progression androgen deprivation therapy Serum testosterone &lt; 50ng/ml 18 year age old Prior taxane therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>Hormone-refractory prostate cancer</keyword>
	<keyword>PET scan</keyword>
	<keyword>C11-methionine</keyword>
	<keyword>positron emission tomography</keyword>
</DOC>